eFFECTOR Therapeutics Inc. (EFTR) Stock Surges Following Promising New Data from Zotatifin Clinical Trial
eFFECTOR Therapeutics Inc. (EFTR) stock prices were up by 12.37% shortly after market trading commenced on October 8th 2021. This brought the price per share